- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CVC
Total 1759 results
-
Mayo ClinicActive, not recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Brazilian Clinical Research InstituteBrainfarma Industria Química e Farmacêutica S/ACompleted
-
Duke UniversityAcist Medical SystemsCompletedPercutaneous Coronary InterventionUnited States
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
Chinese SLE Treatment And Research GroupCHENLIJI Pharmaceutical Company,Guangzhou Pharmaceutical Group; CHINESE RHEUMATISM...Unknown
-
Boehringer IngelheimCompleted
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); United States Department of Defense; National... and other collaboratorsCompleted
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Brain Stem Glioma | Recurrent Childhood Visual Pathway GliomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
AmgenCompletedParapsoriasisUnited States
-
Ramathibodi HospitalKhon Kaen UniversityCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
City of Hope Medical CenterWithdrawnSezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
Mansoura UniversityNot yet recruitingOveractive Bladder | Voiding Disorders
-
Taejoon Pharmaceutical Co., Ltd.CompletedDry Eye | Dry Eye SyndromesKorea, Republic of
-
Brendan BarrettUniversity of British Columbia; Lawson Health Research Institute; Nova Scotia... and other collaboratorsCompletedChronic Kidney DiseaseCanada
-
Cairo UniversityUnknownRespiratory Tract Infections
-
Boehringer IngelheimCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnBreast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
Bruce CreeKyverna TherapeuticsRecruitingProgressive Multiple SclerosisUnited States
-
University of ArizonaOrganonNot yet recruitingContraception
-
Cerevel Therapeutics, LLCCompletedHealthy ParticipantsUnited States
-
National Center of Oncology, ArmeniaBRIU GmbHCompletedAdvanced Breast Cancer | Metastatic Breast CancerArmenia
-
Health DecisionsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedContraceptionUnited States
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
KAZM Pharmaceuticals Inc.McMaster UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterCelgene CorporationActive, not recruitingLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
National Human Genome Research Institute (NHGRI)CompletedMental Retardation | Sleep Disorders, Circadian Rhythm | Developmental Delay Disorders | Chromosome Deletion | Self Injurious BehaviorUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Bristol-Myers Squibb Services Unlimited CompanyRecruitingSystemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory MyopathyUnited States, Belgium, France, Spain, Germany, Italy
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedHematologic DisorderUnited States
-
AmgenCompletedArthritis, PsoriaticUnited States, Spain, Netherlands, Canada, France, Russian Federation, Belgium, Austria, Germany, Italy, United Kingdom
-
CelgeneWithdrawnMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Baystate Medical CenterNot yet recruitingAtrial FibrillationUnited States
-
Cerevel Therapeutics, LLCCompleted
-
Nazarbayev UniversityNational Laboratory AstanaRecruitingMetastatic Colorectal Cancer | Colorectal CancerKazakhstan
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent Prostate CarcinomaUnited States
-
Ataturk UniversityCompletedPeripheral Venous CatheterizationTurkey